The Venture Codex Logo

The Venture Codex

Overview

Precision oncology company developing small-molecule cancer therapies.

Total Raised

$105 M

Rounds

2

Links

Verticals

Biotechnology
Life Science
Medical

Investment History

  1. Series C

    Dec 2019

    $85M

  2. Series A

    Dec 2018

    $20M

Team

David Epstein

Founder, President & Chief Executive Officer

Elizabeth Buck

Founder, Executive Vice President

Alexander Mayweg

Founding, Chief Scientific Officer

Tai-An Lin

Senior Vice President, Translatonal Science and Discovery Biology